The long wait is finally over.
The U.S. Anti-Doping Agency published its case file against the Lance Armstrong Wednesday morning, including sworn statements from more than two dozen witnesses, including 11 former teammates, many whom never tested positive, as well as banking records from a Swiss company controlled by Dr. Michele Ferrari reflecting more than $1 million in payments from Armstrong.
In total, USADA assembled a 1,000-page dossier, which it sent to the Union Cycliste Internationale; the summary alone was 200 pages. Included in the evidence:
Armstrong’s use of EPO and blood transfusions
Jonathan Vaughters saw Armstrong inject himself with EPO during the Vuelta a España in 1998. Tyler Hamilton saw Armstrong take EPO during the 1999 Tour de France. Floyd Landis saw Armstrong use EPO during the 2004 season. George Hincapie, the only rider who was with Armstrong for all seven of his Tour de France victories, said he was aware that Armstrong was using EPO and testosterone throughout the time they were teammates. Hincapie testified that, “from my conversations with Lance Armstrong and experiences with Lance and the team I am aware that Lance used blood transfusions from 2001 through 2005.”
Armstrong encouraged teammates to work with Dr. Michele Ferrari
Testimony from Hincapie, Tom Danielson and Levi Leipheimer states that in 2005 Ferrari provided them advice regarding the use of performance enhancing drugs.
Armstrong threatened teammates for not following Ferrari’s doping regimen
Testimony from Christian Vande Velde states that when Armstrong learned Vande Velde was not strictly adhering to the doping regimen prescribed by Ferrari (including regular use of EPO and testosterone), Armstrong came down hard on Vande Velde in a meeting involving Armstrong, Vande Velde and Ferrari in Armstrong’s Girona, Spain, apartment, following the 2002 Tour de France. Armstrong made it very clear to Vande Velde that if he did not shape up and conform to Ferrari’s doping program that Vande Velde would soon be kicked off the team.
Prior knowledge of unannounced drug tests
Testimony from Dave Zabriskie states that
To read the whole story, visit here: http://velonews.competitor.com/2012/10/news/analysis-what-usadas-case-file-means-to-those-involved_256676